Jonas Eberhard

affiliated with the university, Associate professor
More filtering options
  1. 2019
  2. Manifesto for an international digital mental health network

    Maron, E., Baldwin, D. S., Balõtšev, R., Fabbri, C., Gaur, V., Hidalgo-Mazzei, D., Hood, S., Juhola, M., Kampman, O., Kasper, S., Kärkkäinen, H., Látalová, K., Lähteenvuo, M., Mastellos, N., McTigue, J., Metsallik, J., Metspalu, A., Nutt, D., Nykänen, P., Olisa, N. & 14 othersPogarell, O., Popovic, D., Antoni Ramos-Quiroga, J., Ross, P., Serretti, A., Spies, M., Thibaut, F., Tiainen, K., Tiihonen, J., Vieta, E., Võhma, Ü., Van Westrhenen, R., Belmin Zubanovic & Jonas Eberhard, 2019 Jun 10, In : Digital Psychiatry. 1

    Research output: Contribution to journalArticle

  3. Gender influence on the bipolar disorder inpatient length of stay in Sweden, 2005–2014: A register-based study

    Ragazan, D. C., Jonas Eberhard, Ösby, U. & Jonas Berge, 2019, In : Journal of Affective Disorders. 256, p. 183-191 9 p.

    Research output: Contribution to journalArticle

  4. Outcome of a psychosocial health promotion intervention aimed at improving physical health and reducing alcohol use in patients with schizophrenia and psychotic disorders (MINT)

    Westman, J., Jonas Eberhard, Gaughran, F. P., Lundin, L., Richard Stenmark, Edman, G., Eriksson, S. V., Jedenius, E., Rydell, P., Overgaard, K., Abrams, D., Greenwood, K. E., Smith, S., Ismail, K., Murray, R. & Ösby, U., 2019, In : Schizophrenia Research. 208, p. 138-144

    Research output: Contribution to journalArticle

  5. 2017
  6. Anxiety, irritability, and agitation as indicators of bipolar mania with depressive symptoms: a post hoc analysis of two clinical trials

    Suppes, T., Jonas Eberhard, Lemming, O., Young, A. H. & McIntyre, R. S., 2017 Nov 6, In : International journal of bipolar disorders. 5, 1, 36.

    Research output: Contribution to journalArticle

  7. Sexual dysfunction and central obesity in patients with first episode psychosis

    Theleritis, C., Bonaccorso, S., Habib, N., Stahl, D., Gaughran, F., Vitoratou, S., Atakan, Z., Kolliakou, A., Gardner-Sood, P., Dazzan, P., Marques, T. R., McGuire, P. C., Greenwood, G. K., J Eberhard, Breedvelt, J., Ferracuti, S., Di Forti, M., Murray, R. M. & Smith, S., 2017 May, In : European Psychiatry. 42, p. 1-7 7 p.

    Research output: Contribution to journalArticle

  8. Randomised control trial of the effectiveness of an integrated psychosocial health promotion intervention aimed at improving health and reducing substance use in established psychosis (IMPaCT)

    Gaughran, F., Stahl, D., Ismail, K., Greenwood, K., Atakan, Z., Gardner-Sood, P., Stubbs, B., Hopkins, D., Patel, A., Lally, J., Lowe, P., Arbuthnot, M., Orr, D., Corlett, S., Jonas Eberhard, David, A. S., Murray, R., Smith, S. & the IMPaCT Team, 2017, In : BMC Psychiatry. 17, 1, 413.

    Research output: Contribution to journalArticle

  9. 2016
  10. Social Aspects of the Quality of Life of Persons Suffering from Schizophrenia

    Lee Mortensen, G., De, J., Holme, M., Neve, T., Torell, P. G. & Jonas Eberhard, 2016, In : Open Journal of Psychiatry. 6, p. 50-60

    Research output: Contribution to journalArticle

  11. 2015
  12. Bipolar Patients' Quality of Life in Mixed States: A Preliminary Qualitative Study

    Mortensen, G. L., Vinberg, M., Mortensen, S. L., Jorgensen, M. B. & Jonas Eberhard, 2015, In : Psychopathology. 48, 3, p. 192-201

    Research output: Contribution to journalArticle

  13. Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial

    Gardner-Sood, P., Lally, J., Smith, S., Atakan, Z., Ismail, K., Greenwood, K. E., Keen, A., O'Brien, C., Onagbesan, O., Fung, C., Papanastasiou, E., J Eberhard, Patel, A., Ohlsen, R., Stahl, D., David, A., Hopkins, D., Murray, R. M. & Gaughran, F., 2015, In : Psychological Medicine. 45, 12, p. 2619-29 11 p.

    Research output: Contribution to journalArticle

  14. 2014
  15. Twelve months of electronic monitoring (MEMS®) in the Swedish COAST-study: a comparison of methods for the measurement of adherence in schizophrenia

    Brain, C., Sameby, B., Allerby, K., Lindström, E., Jonas Eberhard, Burns, T. & Waern, M., 2014 Feb, In : European Neuropsychopharmacology. 24, 2, p. 215-22 8 p.

    Research output: Contribution to journalArticle

  16. 2013
  17. Efficacy of asenapine in manic episodes with depressive symptoms: A review of post-hoc analyses

    Young, A. H., Jonas Eberhard & Weiller, E., 2013 Dec 1, In : International Journal of Psychiatry in Clinical Practice. 17, Suppl 2, p. 36-37 P63.

    Research output: Contribution to journalPublished meeting abstract

  18. Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study

    Brain, C., Allerby, K., Sameby, B., Quinlan, P., Joas, E., Karilampi, U., Lindström, E., Jonas Eberhard, Burns, T. & Waern, M., 2013 Dec, In : European Neuropsychopharmacology. 23, 12, p. 1754-62 9 p.

    Research output: Contribution to journalArticle

  19. Metabolic Comorbidity in Psychoses

    Jonas Eberhard (ed.) & Ösby, U. (ed.), 2013, Stockholm: Health & Education Publishing. 44 p.

    Research output: Book/ReportAnthology (editor)

  20. 2011
  21. A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia in Sweden

    Lindström, E., Jonas Eberhard, Fors, B. M., Hansen, K. & Sapin, C., 2011 Dec, In : Nordic Journal of Psychiatry. 65, 6, p. 403-13 11 p.

    Research output: Contribution to journalArticle

  22. The impact study - Motivating a change in health behaviour

    Smith, S., Greenwood, G. K., Atakan, Z., Gardner-Sood, P., Ohlsen, R., Papanastasiou, E., Featherman, A., Todd, G., J. Eberhard, Ismail, K., Murray, R. & Gaughran, F., 2011 Mar 1, In : European Psychiatry. 26, Suppl 1, p. 2151 S39-03.

    Research output: Contribution to journalPublished meeting abstract

  23. 2009
  24. Naturalistic studies - Researching the everyday clinical world

    Malm, U., Fedovskiy, K. & Jonas Eberhard, 2009 Aug 6, In : Nordic Journal of Psychiatry. 63, 2, p. 100-101

    Research output: Contribution to journalDebate/Note/Editorial

  25. Current issues in swedish psychiatry

    Spjut, C. & Jonas Eberhard, 2009 Jan 1, In : Nordic Journal of Psychiatry. 63, 3, p. 270-271 2 p.

    Research output: Contribution to journalArticle

  26. Controversies in Cognition: From Laboratories and Testing to Better Functioning

    Gallhofer, B. (ed.) & Jonas Eberhard (ed.), 2009, Cambridge Medical Communication Ltd. 72 p.

    Research output: Book/ReportAnthology (editor)

  27. Remission in schizophrenia: analysis in a naturalistic setting.

    Jonas Eberhard, Levander, S. & Lindström, E., 2009, In : Comprehensive Psychiatry. 50, 3, p. 200-208

    Research output: Contribution to journalArticle

  28. 2008
  29. Content versus delivery: Challenges and options in the treatment of schizophrenia

    Lublin, H. & Jonas Eberhard, 2008, In : European Neuropsychopharmacology. 18, Suppl. 3, p. V-VI

    Research output: Contribution to journalDebate/Note/Editorial

  30. 2007
  31. Clinical decision-making during 5 years of antipsychotic treatment

    Levander, S., Jonas Eberhard & Lindstrom, E., 2007, In : Acta Psychiatrica Scandinavica. 116, p. 17-26

    Research output: Contribution to journalArticle

  32. Costs of schizophrenia during five years

    Levander, S., Lindstrom, E., Jonas Eberhard & Neovius, M., 2007, In : Schizophrenia Bulletin. 33, 2, p. 485-485

    Research output: Contribution to journalPublished meeting abstract

  33. Costs of schizophrenia during five years

    Lindstrom, E., Jonas Eberhard, Neovius, M. & Levander, S., 2007, In : Acta Psychiatrica Scandinavica. 116, S435, p. 33-40

    Research output: Contribution to journalArticle

  34. Factors predicting patient withdrawal from long-term treatment of schizophrenia

    Jonas Eberhard, Tamminga, C. & Tanghoj, P., 2007, In : Der Nervenarzt. 78, Suppl 2, p. S70

    Research output: Contribution to journalPublished meeting abstract

  35. Five-year follow-up during antipsychotic treatment: efficacy, safety, functional and social outcome

    Lindstrom, E., Jonas Eberhard & Levander, S., 2007, In : Acta Psychiatrica Scandinavica. 116, p. 5-16

    Research output: Contribution to journalArticle

  36. Identification of potential predictors of sertindole response in patients with schizophrenia

    Tamminga, C., Tanghoj, P. & Jonas Eberhard, 2007, In : European Psychiatry. 22, Suppl 1, p. S141-S141

    Research output: Contribution to journalPublished meeting abstract

  37. Nicotine use and its correlates in patients with psychosis

    Levander, S., Jonas Eberhard & Lindstrom, E., 2007, In : Acta Psychiatrica Scandinavica. 116, Suppl. 435, p. 27-32

    Research output: Contribution to journalArticle

  38. Outcome evaluation needed to support evidence-based practice! Preface

    Malm, U. & Jonas Eberhard, 2007, In : Acta Psychiatrica Scandinavica. Supplementum. 435, p. 3-4 2 p.

    Research output: Contribution to journalArticle

  39. Prolactin level during 5 years of risperidone treatment in patients with psychotic disorders.

    Jonas Eberhard, Lindström, E., Holstad, M. & Levander, S., 2007, In : Acta Psychiatrica Scandinavica. 115, 4, p. 268-276

    Research output: Contribution to journalArticle

  40. SCHIZOPHRENIA IN A LONGITUDINAL PERSPECTIVE clinical and neurocognitive aspects

    Jonas Eberhard, 2007, Department of Clinical Sciences, Lund University. 139 p.

    Research output: ThesisDoctoral Thesis (compilation)

  41. Weight development in patients treated with risperidone: a 5-year naturalistic study

    Neovius, M., Jonas Eberhard, Lindstrom, E. & Levander, S., 2007, In : Acta Psychiatrica Scandinavica. 115, 4, p. 277-285

    Research output: Contribution to journalArticle

  42. 2006
  43. Cognition and schizophrenia: improving real life function

    Morgan, K., David, A., Murray, R. & Jonas Eberhard, 2006, Cambridge Medical Communication Ltd. 128 p.

    Research output: Book/ReportBook

  44. Tardive dyskinesia and antipsychotics: a 5-year longitudinal study of frequency, correlates and course.

    Jonas Eberhard, Lindström, E. & Levander, S., 2006, In : International Clinical Psychopharmacology. 21, 1, p. 35-42

    Research output: Contribution to journalArticle

  45. 2005
  46. QTc interval prolongation and antipsychotic drug treatments: focus on sertindole

    Lindstrom, E., Farde, L., Jonas Eberhard & Haverkamp, W., 2005, In : International Journal of Neuropsychopharmacology. 8, 4, p. 615-629

    Research output: Contribution to journalReview article

  47. 2003
  48. Premorbid IQ and schizophrenia Increasing cognitive reduction by episodes.

    Jonas Eberhard, Riley, F. & Levander, S., 2003, In : European Archives of Psychiatry and Clinical Neuroscience. 253, 2, p. 84-88

    Research output: Contribution to journalArticle

  49. 1998
  50. Social cognition, symptom profile, and quality of life in schizophrenia

    Lögdberg, B., Nilsson, L. L. & Jonas Eberhard, 1998, In : Nordic Journal of Psychiatry, Supplement. 52, 41, p. 200-201 2 p.

    Research output: Contribution to journalPublished meeting abstract